Influence of subinhibitory concentrations of NH125 on biofilm formation & virulence factors of Staphylococcus aureus

Future Medicinal Chemistry
Qingzhong LiuEleftherios Mylonakis

Abstract

l-benzyl-3-cetyl-2-methylimidazolium iodide (NH125) can inhibit Staphylococcus aureus growth. We investigated the effects of sub-MIC concentrations of NH125 on S. aureus biofilm and virulence. Methodology & results: Three strains of S. aureus were tested. Sub-lethal concentrations of NH125 repressed biofilm formation. At partial sub-MICs, NH125 downregulated the expression of most virulence, while strain-dependent effects were found in the production of α-hemolysin, δ-hemolysin, coagulase and nuclease. In Galleria mellonella model, methicillin-resistant S. aureus pre-exposed to NH125 demonstrated significantly lower killing (p = 0.032 for 1/16 and 1/8 MICs; 0.008 for 1/4 MIC; and 0.001 for 1/2 MIC). Sub-MIC concentrations of NH125 inhibited biofilm formation and virulence of S. aureus. These findings provide further support for evaluating the clinical efficacy of NH125 in staphylococcal infection.

References

Jan 11, 2000·Clinical Microbiology Reviews·M M DingesP M Schlievert
Jun 1, 2000·Bioscience, Biotechnology, and Biochemistry·K YamamotoR Utsumi
Nov 9, 2000·The Journal of Infectious Diseases·C VuongM Otto
Jan 5, 2002·Bioscience, Biotechnology, and Biochemistry·K YamamotoR Utsumi
Jan 18, 2002·Infection and Immunity·Jon S BlevinsMark S Smeltzer
Jun 24, 2003·Infection and Immunity·Karen E BeenkenMark S Smeltzer
Jan 27, 2004·Antimicrobial Agents and Chemotherapy·Katussevani BernardoMartin Krönke
Mar 26, 2004·Nature Reviews. Microbiology·Luanne Hall-StoodleyPaul Stoodley
Jul 3, 2004·Journal of Bacteriology·Karen E BeenkenMark S Smeltzer
Jul 8, 2005·Applied and Environmental Microbiology·Dacheng RenThomas K Wood
Dec 3, 2005·Nature Reviews. Microbiology·Timothy J Foster
Jan 20, 2009·Peptides·Julien VerdonYann Héchard
Feb 12, 2009·Chembiochem : a European Journal of Chemical Biology·Thomas Böttcher, Stephan A Sieber
Aug 15, 2009·Nature Reviews. Microbiology·Henry F Chambers, Frank R Deleo
Jan 9, 2010·The Journal of Antibiotics·Ario OkadaRyutaro Utsumi
Feb 9, 2010·Current Opinion in Microbiology·Yasuhiro GotohRyutaro Utsumi
Jul 20, 2010·Applied and Environmental Microbiology·Jiazhang QiuXuming Deng
Sep 10, 2010·Annual Review of Microbiology·Tino KrellJuan Luis Ramos
Sep 28, 2010·Journal of Bacteriology·Diego O AndreyWilliam L Kelley
May 5, 2011·FEMS Immunology and Medical Microbiology·Ludwig StenzJacques Schrenzel
Aug 29, 2012·Antimicrobial Agents and Chemotherapy·Jongkon SaisingFriedrich Götz
Dec 18, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Martin E Stryjewski, G Ralph Corey
Mar 4, 2014·Current Opinion in Microbiology·Michael Otto
Jan 8, 2015·Frontiers in Cellular and Infection Microbiology·Jessica L Lister, Alexander R Horswill
May 29, 2015·Clinical Microbiology Reviews·Steven Y C TongVance G Fowler
Nov 19, 2015·Frontiers in Microbiology·Katherine Y Le, Michael Otto
Feb 26, 2016·Future Medicinal Chemistry·Wooseong KimEleftherios Mylonakis

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.